Prosecution Insights
Last updated: May 29, 2026

Two Cells Co. Ltd.

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Portfolio Summary

2
Total Pending OAs
0
Non-Final OAs
2
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

2
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
2
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only2 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
KIM, TAEYOON 1 51.5% +51.4%
VAN BUREN, LAUREN K 1 38.9% +57.3%

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
18011367 COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, METHOD FOR PRODUCING COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, AND METHOD FOR PRODUCING THERAPEUTIC FORMULATION FOR CENTRAL NERVOUS SYSTEM DISEASES KIM, TAEYOON 44d overdue
16634820 COMPOSITION FOR CRYOPRESERVATION, METHOD FOR PRODUCING CRYOPRESERVED MATERIAL, CELL PREPARATION, METHOD FOR PRODUCING CELL PREPARATION, AND KIT FOR CRYOPRESERVATION VAN BUREN, LAUREN K 24d overdue

Top Art Units

Art UnitApps
1631 1
1638 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18011367 COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, METHOD FOR PRODUCING COMPOSITION FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES, AND METHOD FOR PRODUCING THERAPEUTIC FORMULATION FOR CENTRAL NERVOUS SYSTEM DISEASES KIM, TAEYOON 1631 §103 Final Rejection 44d overdue Pending Dec 19, 2022
16634820 COMPOSITION FOR CRYOPRESERVATION, METHOD FOR PRODUCING CRYOPRESERVED MATERIAL, CELL PREPARATION, METHOD FOR PRODUCING CELL PREPARATION, AND KIT FOR CRYOPRESERVATION VAN BUREN, LAUREN K 1638 §103 Final Rejection 24d overdue Pending Jan 28, 2020

Managing Two Cells Co. Ltd.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month